Northwestern Mutual Wealth Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-470
Closed -$343 4404
2026
Q1
$343 Buy
470
+5
+1% +$23 ﹤0.01% 3889
2025
Q4
$2.59K Hold
465
﹤0.01% 3408
2025
Q3
$3.43K Hold
465
﹤0.01% 3261
2025
Q2
$3.54K Hold
465
﹤0.01% 3111
2025
Q1
$8.87K Hold
465
﹤0.01% 2786
2024
Q4
$16.8K Hold
465
﹤0.01% 2572
2024
Q3
$13.4K Hold
465
﹤0.01% 2591
2024
Q2
$11.9K Hold
465
﹤0.01% 2584
2024
Q1
$35.1K Hold
465
﹤0.01% 2220
2023
Q4
$47.9K Hold
465
﹤0.01% 2077
2023
Q3
$45.4K Hold
465
﹤0.01% 2006
2023
Q2
$54.5K Hold
465
﹤0.01% 1947
2023
Q1
$39K Hold
465
﹤0.01% 2034
2022
Q4
$39.5K Hold
465
﹤0.01% 1992
2022
Q3
$15K Hold
465
﹤0.01% 2329
2022
Q2
$10K Hold
465
﹤0.01% 2522
2022
Q1
$23K Hold
465
﹤0.01% 2259
2021
Q4
$27K Buy
+465
New +$33.1K ﹤0.01% 2206

Other funds holding RVPH

Northwestern Mutual Wealth Management's RVPH Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 470 shares — an estimated $343 sold.

Northwestern Mutual Wealth Management first reported a position in RVPH in Q4 2021 and held it in 18 quarters. The position peaked at $54.5K in Q2 2023. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

  • Northwestern Mutual Wealth Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 470 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $343.
  • Northwestern Mutual Wealth Management first reported a position in REVIVA PHARMA HLDGS INC in Q4 2021 and held it in 18 quarters.
  • Northwestern Mutual Wealth Management's REVIVA PHARMA HLDGS INC position peaked at $54.5K in Q2 2023.
  • 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.